Thermo Fisher Scientific Inc (NYSE:TMO)
| 607.61 Delayed Data As of Oct 25 |  -0.145 / -0.02%Today’s Change | 433.52 Today|||52-Week Range 616.93 | +30.45% Year-to-Date |
Latest TMO News | Press Releases
Today’s Trading
| Previous close | 607.75 |
| Today’s open | 611.61 |
| Day’s range | 602.58 - 611.61 |
| Volume | 11,579 |
| Average volume (3 months) | 1,234,435 |
| Market cap | $240.8B |
Data as of 3:59pm ET, 10/25/2021
Growth & Valuation
| Earnings growth (last year) | +74.23% |
| Earnings growth (this year) | +13.63% |
| Earnings growth (next 5 years) | +9.90% |
| Revenue growth (last year) | +26.14% |
| P/E ratio | 28.1 |
| Price/Sales | 5.77 |
| Price/Book | 7.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DHRDanaher Corp | +0.15 | +0.05% |
| AAgilent Technologies... | +0.03 | +0.02% |
| MTDMettler-Toledo Inter... | +2.57 | +0.17% |
| WATWaters Corp | +0.12 | +0.03% |
Data as of 4:00pm ET, 10/25/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $4.68 |
| Annual revenue (last year) | $32.2B |
| Annual profit (last year) | $6.4B |
| Net profit margin | 19.79% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
